Schedule 13D ownership disclosure
Acer Therapeutics Inc.
Security class unavailable · CUSIP: 00444P108
Event date: 2017-09-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.1800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-17-004294
- Form type
- SC 13D
- Filer
- AVEGO HEALTHCARE CAPITAL, LLC
- CIK
- CIK 1718225
- Filed
- Sep 28, 2017
- Reporting period
- Sep 19, 2017
- Description
- Schedule 13D beneficial ownership